IPG Moves Corporate Headquarters to New Location in Support of Continued Business Expansion

ATLANTA--(BUSINESS WIRE)--IPG, the leading nationwide provider of Implantable Device Benefit Management™ (DBM) solutions, is pleased to announce that it has moved its corporate headquarters to a new location in Alpharetta, Georgia. The new 23,000 plus square foot corporate headquarters marks IPG’s sixth office expansion since 2004 and is a strategic move to support the rapid adoption of the company’s core DBM Model and product expansion initiatives.

“IPG is addressing the large, unmanaged implantable device market of $125 billion in health plan annual spend”

“IPG is addressing the large, unmanaged implantable device market of $125 billion in health plan annual spend,” said Jay Ethridge, President and CEO of IPG. “We could not be more proud of our team and the success the expanded space represents for us and for our business, as we continue to implement programs that positively impact cost, quality and affordability of care related to implantable procedures.”

With the rapid adoption of our Device Benefit Management model, we are pleased to be recognized as the thought leader in this space and our move to an expanded space is linked to supporting our referable customer base, significant pipeline and utilization of our patent-pending technology and device algorithms to launch new products that will continue to address the market nationwide.

Ranked #5 on Forbes’ 2011 List of America’s Most Promising Companies, IPG was most recently named Winner of 2012 Inc. Hire Power Award, recognizing private businesses that have generated the most jobs in the past three years and was named to the Inc. 500|5000 List of Fastest Growing Private Companies for Third Consecutive Year.

As of December 10, IPG’s new address is 11605 Haynes Bridge Road, Suite 200, Alpharetta, GA 30009. IPG telephone numbers and email addresses will remain the same.

About IPG

As the leading provider of Device Benefit Management solutions, IPG provides high quality, affordable implantable device solutions to address the critical need of reducing overall healthcare costs. The company has pioneered a unique DBM model which streamlines the management and delivery of implantable devices by working directly with health plans, clinical providers, facilities and medical device manufacturers. IPG delivers implant intelligence surrounding the overall cost and quality of healthcare being delivered, adding transparency and control of spend in tandem with the implementation of quality metrics necessary to drive and reward best practices. This approach ensures that patients receive increased access to affordable and innovative life-saving and life-enhancing device-intensive medical therapies. For more information about IPG, call us at 1-866-753-0046, or visit us on the web at www.ipg.com.